A flawed agenda

The Government’s current narrow focus on 60-day dispensing and the $1 discount is doing little to ease fears that universal access to medicines is under threat from its determination to cut costs regardless of long-term outcomes, says Anthony Tassone It is clear there is a blinkered view about these two policies – flawed as they